Li Ka Shing Foundation, Temasek Trust jointly commit $9M to acquire systems and advance clinical trial for innovative histotripsy cancer therapy in Singapore
The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million ($8.99 million) to bring innovative non-invasive ultrasound-based histotripsy tumor clinical trials to Singapore. The duo said in a statement on Friday that the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) will each receive one Histotripsy System...
0 Σχόλια 0 Μοιράστηκε 516 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο